Tag

Business Separation

All articles tagged with #business separation

Johnson & Johnson to Spin Off Orthopedics Division

Originally Published 2 months ago — by MassDevice

Featured image for Johnson & Johnson to Spin Off Orthopedics Division
Source: MassDevice

Johnson & Johnson announced plans to spin off its DePuy Synthes Orthopaedics business to enhance focus and growth, creating a standalone orthopaedics company expected to be the largest in its field, with a strategic move aimed at boosting margins and market share, led by newly appointed president Namal Nawana.

Diddy Sells Majority Stake in Revolt to Employees

Originally Published 1 year ago — by Newser

Featured image for Diddy Sells Majority Stake in Revolt to Employees
Source: Newser

Sean "Diddy" Combs' business empire continues to decline as he sells his shares in Revolt, steps down from his chairman role, and faces multiple accusations of abuse. Revolt, now employee-owned, distances itself from Combs, who has also sold his stake in the tequila brand DeLeón and lost a Hulu reality show.

BlackBerry Appoints John Giamatteo as CEO, Abandons IPO Plans

Originally Published 2 years ago — by BlackBerry

BlackBerry has appointed John J. Giamatteo as its new CEO and announced the full separation of its IoT and Cybersecurity business units, which will operate as standalone divisions. The company will no longer pursue an IPO for its IoT business. The restructuring process will involve streamlining centralized functions and right-sizing cost structures. The move is aimed at enhancing shareholder value and providing greater options for the company's future.

Kenvue, J&J's Consumer Health Spinoff, Soars in Public Debut

Originally Published 2 years ago — by CNBC

Featured image for Kenvue, J&J's Consumer Health Spinoff, Soars in Public Debut
Source: CNBC

Johnson & Johnson's consumer-health unit Kenvue soared more than 22% on its first day of trading, bringing the company one step closer to completing its business separation. The planned split, set for later this year, is in the best interest of shareholders of both the soon-to-be-solo Kenvue operations and the new pharma and medtech-focused J&J.